Pancreatic cancer epidemiology

Technology in Cancer Research and Treatment

Volumn 4, Issue 3, 2005, Pages 295-301

  Verma, Mukesh ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BIOLOGICAL MARKER; BRCA2 PROTEIN; CA 19-9 ANTIGEN; CALRETICULIN; CHOLECYSTOKININ RECEPTOR; CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1; HYDROCARBON; K RAS PROTEIN; MEMBRANE PROTEIN; ORGANOCHLORINE DERIVATIVE; OSTEOPONTIN; PROTEIN KINASE LKB1; PROTEIN L38; PROTEIN MLH1; PROTEIN P14; PROTEIN P16; RANTES; RIBOSOME PROTEIN; SURVIVIN; TRANSCRIPTION FACTOR FRA 1; UNCLASSIFIED DRUG; URIDINE PHOSPHORYLASE;

ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CANCER SURVIVAL; CIGARETTE SMOKING; COFFEE; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; EPIGENETICS; GENETIC POLYMORPHISM; HEREDITY; HUMAN; LIFESTYLE; PANCREAS CANCER; PREVALENCE; PROTEOMICS; RISK FACTOR;

EID: 20444417778     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460500400309     Document Type: Article

References (63)

1. Safioleas, M. C., Moulakakis, K. G. Pancreatic Cancer Today. Hepatogastroenterology 51, 862-868 (2004).
2. Skinner, H. G., Michaud, D. S., Giovannucci, E. L., et al. A Prospective Study of Folate Intake and the Risk of Pancreatic Cancer in Men and Women. Am J Epidemiol 160, 248-258 (2004).
3. Takhar, A.S., Palaniappan, P., Dhingsa, R., Lobo, D. N. Recent Developments in Diagnosis of Pancreatic Cancer. Bmj 329, 668-673 (2004).
4. Holly, E. A., Chaliha, I., Bracci, P. M., Gautam, M. Signs and Symptoms of Pancreatic Cancer: A Population-based Case-control Study in the San Francisco Bay Area. Clin Gastroenterol Hepatol 2, 510-517 (2004).
5. Rosty, C. Towards the Identification of Mew Markers of Pancreatic Cancer by Gene Expression Analysis. Bull Cancer 91, 593-598 (2004).
6. Michaud, D. S. Epidemiology of Pancreatic Cancer. Minerva Chir 59, 99-111 (2004).
7. Villeneuve, P. J., Johnson, K. C., Mao, Y., Hanley, A. J. Environmental Tobacco Smoke and the Risk of Pancreatic Cancer: Findings from a Canadian Population-based Case-control Study. Can J Public Health 95, 32-37 (2004).
8. Van Laar, E. S., Roth, S., Weitman, S., MacDonald, J. R., Waters, S. J. Activity of Irofulven Against Human Pancreatic Carcinoma Cell Lines In Vitro and In Vivo. Anticancer Res 24, 59-65 (2004).
9. Alexandrov, K., Rojas, M., Kadlubar, F. F., Lang, N. P., Bartsch, H. Evidence of Anti-benzo[a]pyrene Diolepoxide-DNA Adduct Formation in Human Colon Mucosa. Carcinogenesis 17, 2081-2083 (1996).
10. Shirai T, Nakamura A, Fukushima S, Tada M, Morita T, Ito N. Immunohistochemical Demonstration of Carcinogen-DNA Adducts in Target and Non-target Tissues of Rats Given a Prostate Carcinogen, 3,2′-dimethyl-4- aminobiphenyl. Carcinogenesis 11, 653-657 (1990).
11. Li, D., Jiao, L. Molecular Epidemiology of Pancreatic Cancer. Int J Gastrointest Cancer 33, 3-14 (2003).
12. Coss, A., Cantor, K. P., Reif, J. S., Lynch, C. F., Ward, M. H. Pancreatic Cancer and Drinking Water and Dietary Sources of Nitrate and Nitrite. Am J Epidemiol 159,693-701 (2004).
13. Lowenfels, A. B., Maisonneuve, P. Epidemiology and Prevention of Pancreatic Cancer. Jpn J Clin Oncol 34, 238-244 (2004).
14. Michaud, D. S., Giovannucci, E., Willett, W. C., Colditz, G. A., Fuchs, C. S. Dietary Meat, Dairy Products, Fat, and Cholesterol and Pancreatic Cancer Risk in a Prospective Study. Am J Epidemiol 157, 1115-1125 (2003).
15. Anderson, K. E., Sinha, R., Kulldorff, M., et al. Meat Intake and Cooking Techniques: Associations with Pancreatic Cancer. Mutat Res 506-507, 225-231 (2002).
16. Rulyak, S. J., Brentnall, T. A., Lynch, H. T., Austin, M. A. Characterization of the Neoplastic Phenotype in the Familial Atypical Multiple-mole Melanoma-pancreatic Carcinoma Syndrome. Cancer 98, 798-804 (2003).
17. Jorgensen, M. T., Schaffalitzky de Muckadell, O. B. Hereditary Pancreatitis. Ugeskr Laeger 165, 447-451 (2003).
18. Luttges, J., Hahn, S., Kloppel, G. Where and When Does Pancreatic Carcinoma Start? Med Klin (Munich) 99, 191-195 (2004).
19. Rulyak, S. J., Brentnall, T. A. Inherited Pancreatic Cancer: Improvements in our Understanding of Genetics and Screening. Int J Biochem Cell Biol 36, 1386-1392 (2004).
20. Geoffroy-Perez, B., Janin, N., Ossian, K., et al. Cancer Risk in Heterozygotes for Ataxia-telangiectasia. Int J Cancer 93,288-293 (2001).
21. Yu, G., Zhu, M. H., Zhu, Z., Ni, C. R., Zheng, J. M., Li, F. M. Expression of ATM Protein and Its Relationship with p53 in Pancreatic Carcinoma with Tissue Array. Pancreas 28, 421-426 (2004).
22. Lim, W., Olschwang, S., Keller, J. J., et al. Relative Frequency and Morphology of Cancers in STK11 Mutation Carriers. Gastroenterology 126, 1788-1794 (2004).
23. Lynch, H. T., Shaw, T. G., Lynch, J. F. Inherited Predisposition to Cancer: A Historical Overview. Am J Med Genet 129C, 5-22 (2004).
24. Aguirre, A. J., Brennan, C., Bailey, G., et al. High-resolution Characterization of the Pancreatic Adenocarcinoma Genome. Proc Natl Acad Sci USA 101, 9067-9072 (2004).
25. Shirahama, S., Matsuyoshi, J., Yamamoto, S., Tsukada, Y. Alteration of the K-ras and p16/CDKN2 Gene in Endocrine Pancreatic Carcinomas. Nippon Rinsho 62, 889-893 (2004).
26. de Bruin, W. C., Wagenmans, M. J., Peters, W. H. Expression of Glutathione S-transferase Alpha, P1-1 and T1-1 in the Human Gastrointestinal Tract. Jpn J Cancer Res 91, 310-316 (2000).
27. Coles, B. F., Anderson, K. E., Doerge, D. R., Churchwell, M. I., Lang, N. P., Kadlubar, F. F. Quantitative Analysis of Interindividual Variation of Glutathione S-transferase Expression in Human Pancreas and the Ambiguity of Correlating Genotype with Phenotype. Cancer Res 60, 573-579 (2000).
28. Takaya, H., Andoh, A., Shimada, M., Hata, K., Fujiyama, Y., Bamba, T. The Expression of Chemokine Genes Correlates with Nuclear Factor-kappaB Activation in Human Pancreatic Cancer Cell Lines. Pancreas 21, 32-40 (2000).
29. Coughlin, S. S., Calle, E. E., Teras, L. R., Petrelli, J., Thun, M. J. Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults. Am J Epidemiol 159, 1160-1167 (2004).
30. Wagner, P. D., Verma, M., Srivastava, S. Challenges for Biomarkers in Cancer Detection. Ann N Y Acad Sci 1022, 9-16 (2004).
31. Verma, M., Srivastava, S. New Cancer Biomarkers Deriving from NCI Early Detection Research. Recent Results Cancer Res 163, 72-84; Discussion 264-266 (2003).
32. Verma, M., Srivastava, S. Epigenetics in Cancer: Implications for Early Detection and Prevention. Lancet Oncol 3, 755-763 (2002).
33. Srinivas, P. R., Verma, M., Zhao, Y, Srivastava, S. Proteomics for Cancer Biomarker Discovery. Clin Chem 48, 1160-1169 (2002).
34. Negm, R. S., Verma, M., Srivastava, S. The Promise of Biomarkers in Cancer Screening and Detection. Trends Mol Med 8, 288-293 (2002).
35. Verma, M., Wright, G. L., Jr., Hanash, S. M., Gopal-Srivastava, R., Srivastava, S. Proteomic Approaches Within the NCI Early Detection Research Network for the Discovery and Identification of Cancer Biomarkers. Ann N Y Acad Sci 945, 103-115 (2001).
36. Grizzle, W. E., Adam, B. L., Bigbee, W. L., et al. Serum Protein Expression Profiling for Cancer Detection: Validation of a SELDI-based Approach for Prostate Cancer. Dis Markers 19, 185-195 (2003).
37. Verma, M. Biomarkers for Risk Assessment in Molecular Epidemiology of Cancer. Technol Cancer Res Treat 3,505-514 (2004).
38. Verma, M., Kagan, J., Sidransky, D., Srivastava, S. Proteomic Analysis of Cancer-cell Mitochondria. Nat Rev Cancer 3, 789-795 (2003).
39. House, M. G., Herman, J. G., Guo, M. Z., et al. Aberrant Hypermethylation of Tumor Suppressor Genes in Pancreatic Endocrine Neoplasms. Ann Surg 238, 423-431; Discussion 431-432 (2003).
40. Uemura, T., Hibi, K., Kaneko, T., et al. Detection of K-ras Mutations in the Plasma DNA of Pancreatic Cancer Patients. J Gastroenterol 59, 56-60 (2004).
41. Simon, B., Lubomierski, N. Implication of the INK4a/ARF Locus in Gastroenteropancreatic Neuroendocrine Tumorigenesis. Ann NY Acad Sci 1014, 284-299 (2004).
42. Sakai, M., Hibi, K., Koshikawa, K., et al. Frequent Promoter Methylation and Gene Silencing of CDH13 in Pancreatic Cancer. Cancer Sci 95, 588-591 (2004).
43. Zhou, G. X., Huang, J. F., Li, Z. S., Xu, G. M., Liu, F., Zhang, H. Detection of K-ras Point Mutation and Telomerase Activity during Endoscopic Retrograde Cholangiopancreatography in Diagnosis of Pancreatic Cancer. World J Gastroenterol 10, 1337-1340 (2004).
44. Sahin, F., Qiu, W., Wilentz, R. E., Iacobuzio-Donahue, C. A., Grosmark, A., Su, G. H. RPL38, FOSL1, and UPP1 are Predominantly Expressed in the Pancreatic Ductal Epithelium. Pancreas 30, 158-167 (2005).
45. Hustinx, S. R., Cao, D., Maitra, A., et al. Differentially Expressed Genes in Pancreatic Ductal Adenocarcinomas Identified Through Serial Analysis of Gene Expression. Cancer Biol Ther 3, (2004).
46. Heidenblut, A. M., Luttges, J., Buchholz, M., et al. aRNA-longSAGE: A New Approach to Generate SAGE Libraries from Microdissected Cells. Nucleic Acids Res 32, e131 (2004).
47. Stein, W. D., Litman, T., Fojo, T., Bates, S. E. A Serial Analysis of Gene Expression (SAGE) Database Analysis of Chemosensitivity: Comparing Solid Tumors with Cell Lines and Comparing Solid Tumors from Different Tissue Origins. Cancer Res 64, 2805-2816 (2004).
48. Buckhaults, P., Zhang, Z., Chen, Y. C., et al. Identifying Tumor Origin Using a Gene Expression-based Classification Map. Cancer Res 63, 4144-4149 (2003).
49. Oien, K. A., Vass, J. K., Downie, I., Fullarton, G., Keith, W. N. Profiling, Comparison and Validation of Gene Expression in Gastric Carcinoma and Normal Stomach. Oncogene 22, 4287-4300 (2003).
50. Hong, S. H., Misek, D. E., Wang, H., et al. An Autoantibody-mediated Immune Response to Calreticulin Isoforms in Pancreatic Cancer. Cancer Res 64, 5504-5510 (2004).
51. Rosty, C., Goggins, M. Identification of Differentially Expressed Proteins in Pancreatic Cancer Using a Global Proteomic Approach. Methods Mol Med 103, 189-198 (2004).
52. Gronborg, M., Bunkenborg, J., Kristiansen, T. Z., et al. Comprehensive Proteomic Analysis of Human Pancreatic Juice. J Proteome Res 3, 1042-1055 (2004).
53. Verma, M., Dunn, B. K., Ross, S., et al. Early Detection and Risk Assessment: Proceedings and Recommendations from the Workshop on Epigenetics in Cancer Prevention. Ann NY Acad Sci 983, 298-319 (2003).
54. Verma M. Viral Genes and Methylation. Ann NY Acad Sci 983, 170-180 (2003).
55. Dunn, B. K., Verma, M., Umar, A. Epigenetics in Cancer Prevention: Early Detection and Risk Assessment: Introduction. Ann NY Acad Sci 983, 1-4 (2003).
56. Klump, B., Hsieh, C. J., Nehls, O., et al. Methylation Status of p14ARF and p16INK4a as Detected in Pancreatic Secretions. Br J Cancer 88, 211-222 (2003).
57. Cleary, S. P., Gryfe, R., Guindi, M., et al. Prognostic Factors in Resected Pancreatic Adenocarcinoma: Analysis of Actual 5-year Survivors. J Am Coll Surg 198, 722-731 (2004).
58. Hruban, R. H., Takaori, K., Klimstra, D. S., et al. An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms. Am J Surg Pathol 28, 977-987 (2004).
59. House, M. G., Herman, J. G., Guo, M. Z., et al. Prognostic Value of hMLH1 Methylation and Microsatellite Instability in Pancreatic Endocrine Neoplasms. Surgery 134,902-908; Discussion 909 (2003).
60. Sawabu, N., Watanabe, H., Yamaguchi, Y., Ohtsubo, K., Motoo, Y. Serum Tumor Markers and Molecular Biological Diagnosis in Pancreatic Cancer. Pancreas 28, 263-267 (2004).
61. Kim, J. E., Lee, K. T., Lee, J. K., Paik, S. W., Rhee, J. C., Choi, K. W. Clinical Usefulness of Carbohydrate Antigen 19-9 as a Screening Test for Pancreatic Cancer in an Asymptomatic Population. J Gastroenterol Hepatol 19, 182-186 (2004).
62. Koopmann, J., Fedarko, N. S., Jain, A., et al. Evaluation of Osteopontin as Biomarker for Pancreatic Adenocarcinoma. Cancer Epidemiol Biomarkers Prev 13, 487-491 (2004).
63. Kami K, Doi R, Koizumi M, et al. Survivin expression is a prognostic marker in pancreatic cancer patients. Surgery 2004;136(2):443-8.